Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Fong

Showing results (131-140 of 198) with videos related to

Pageof 20
Sort By:
JHEP Reports : Innovation in Hepatology|March 14, 2026
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunctionBridget P Keenan, Zenghua Fan, Bryan Khuong Le, et al.
JCI Insight|April 29, 2025
Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancerSerena S Kwek, Hai Yang, Tony Li, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Experimental Medicine|April 1, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune responseMiho Tanaka, Lotus Lum, Kenneth H Hu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
Cell Reports|September 21, 2022
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysisBridget P Keenan, Elizabeth E McCarthy, Arielle Ilano, et al.
JCI Insight|February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2026
Functionally heterogeneous intratumoral CD4<sup>+</sup>CD8<sup>+</sup> double-positive T cells can give rise to single-positive T cellsTony Li, Arielle Ilano, Marcel Arias-Badia, et al.
Pageof 20

Showing results (131-140 of 198) with videos related to

Sort By:
Pageof 20
JHEP Reports : Innovation in Hepatology|March 14, 2026
Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunctionBridget P Keenan, Zenghua Fan, Bryan Khuong Le, et al.
JCI Insight|April 29, 2025
Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancerSerena S Kwek, Hai Yang, Tony Li, et al.
Cancer Immunology Research|October 1, 2016
Systemic GM-CSF Recruits Effector T Cells into the Tumor Microenvironment in Localized Prostate CancerXiao X Wei, Stephen Chan, Serena Kwek, et al.
The Journal of Experimental Medicine|April 1, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune responseMiho Tanaka, Lotus Lum, Kenneth H Hu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic CancerAndrew H Ko, Alexander C Jordan, Evan Tooker, et al.
Cell Reports|September 21, 2022
Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysisBridget P Keenan, Elizabeth E McCarthy, Arielle Ilano, et al.
JCI Insight|February 27, 2025
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4Marcel Arias-Badia, PeiXi Chen, Yee May Lwin, et al.
Science Immunology|April 14, 2022
Androgen conspires with the CD8<sup>+</sup> T cell exhaustion program and contributes to sex bias in cancerHyunwoo Kwon, Johanna M Schafer, No-Joon Song, et al.
Urologic Oncology|November 26, 2022
Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracersDaniel H Kwon, Nonna Shakhnazaryan, David Shui, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 2026
Functionally heterogeneous intratumoral CD4<sup>+</sup>CD8<sup>+</sup> double-positive T cells can give rise to single-positive T cellsTony Li, Arielle Ilano, Marcel Arias-Badia, et al.
Pageof 20